Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21639808

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2011 Jun 30
First author
Chapman PB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Jun 30;364(26):2547-8. doi: 10.1056/NEJMe1105792.
    note
    Source null
    related pmid
    21639809
    relationship
    Comment in
  2. citation
    N Engl J Med. 2011 Oct 13;365(15):1448; author reply 1450. doi: 10.1056/NEJMc1108651.
    note
    Source null
    related pmid
    21995398
    relationship
    Comment in
  3. citation
    N Engl J Med. 2011 Oct 13;365(15):1448-9; author reply 1450. doi: 10.1056/NEJMc1108651.
    note
    Source null
    related pmid
    21995399
    relationship
    Comment in
  4. citation
    N Engl J Med. 2011 Oct 13;365(15):1449-50; author reply 1450. doi: 10.1056/NEJMc1108651.
    note
    Source null
    related pmid
    21995400
    relationship
    Comment in

Authors and identifiers

  1. name
    Chapman PB
    type
    Author
  2. name
    Hauschild A
    type
    Author
  3. name
    Robert C
    type
    Author
  4. name
    Haanen JB
    type
    Author
  5. name
    Ascierto P
    type
    Author
  6. name
    Larkin J
    type
    Author
  7. name
    Dummer R
    type
    Author
  8. name
    Garbe C
    type
    Author
  9. name
    Testori A
    type
    Author
  10. name
    Maio M
    type
    Author
  11. name
    Hogg D
    type
    Author
  12. name
    Lorigan P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Chapman PB
    type
    Author
  2. name
    Hauschild A
    type
    Author
  3. name
    Robert C
    type
    Author
  4. name
    Haanen JB
    type
    Author
  5. name
    Ascierto P
    type
    Author
  6. name
    Larkin J
    type
    Author
  7. name
    Dummer R
    type
    Author
  8. name
    Garbe C
    type
    Author
  9. name
    Testori A
    type
    Author
  10. name
    Maio M
    type
    Author
  11. name
    Hogg D
    type
    Author
  12. name
    Lorigan P
    type
    Author
bibliography ids
  1. nci-bib-cb52d5e0d6f95cdd2759b60b
book metadata
content sha256
02d6b0e2ca4e3c878a08137c8f6ab2c1ea85aa4bb5e7a398b2134ba7af69b73e
document type
citation
dois
  1. 10.1056/NEJMoa1103782
electronic publication date
display
2011 Jun 5
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21639808
immutable id
pubmed:21639808@02d6b0e2ca4e3c878a08137c8f6ab2c1ea85aa4bb5e7a398b2134ba7af69b73e
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2507-16
volume
364
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Jun 30;364(26):2547-8. doi: 10.1056/NEJMe1105792.
    note
    Source null
    related pmid
    21639809
    relationship
    Comment in
  2. citation
    N Engl J Med. 2011 Oct 13;365(15):1448; author reply 1450. doi: 10.1056/NEJMc1108651.
    note
    Source null
    related pmid
    21995398
    relationship
    Comment in
  3. citation
    N Engl J Med. 2011 Oct 13;365(15):1448-9; author reply 1450. doi: 10.1056/NEJMc1108651.
    note
    Source null
    related pmid
    21995399
    relationship
    Comment in
  4. citation
    N Engl J Med. 2011 Oct 13;365(15):1449-50; author reply 1450. doi: 10.1056/NEJMc1108651.
    note
    Source null
    related pmid
    21995400
    relationship
    Comment in
outcomes validated
false
pmid
21639808
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
ed44c2e7ddc60240c77e30304e77f9d23023000d5039da17e66c7b58599d00db
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 Jun 30
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21639808/
title
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

Preserved source evidence · Not medical advice